5. Grossman LD. New solutions for type 2 diabetes: the role of pioglitazone. Pharmacoeconomics 2002;20(Suppl 1):1-9.
6. Sourij H, Wascher TC. Pioglitazone in the management of type 2 diabetes and beyond. Therapy 2007: 4: 517-33.
8. FDA. ACTOS™ (Pioglitazone Hydrochloride) Tablets. Highlights of Prescribing Information, 1999. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021073s043s044lbl.pdf
27. Food and Drug Administration. FDA Drug Safety Communication: Updated FDA review concludes that use of type 2 diabetes medicine pioglitazone may be linked to an increased risk of bladder cancer. 2016. https://www.fda.gov/Drugs/DrugSafety/ucm519616.htm